EVOLUTE® EXPRESS WCX combines non-polar and weak cation exchange functionality for extraction of strongly basic analytes (e.g. quaternary amines) from biological fluids and other aqueous samples through a dual, mixed-mode mechanism.
This provides additional selectivity and clean-up for complex samples, with salts, phospholipids and proteins eliminated from extracts.
Available in a variety of formats, including 96-well plates and SPE columns, and two different particle sizes (30 µm and 50 µm) depending on application requirements.
The sorbent consists of the EVOLUTE® backbone, surface modified with carboxylic acid groups. Sorbent performance is not compromised by drying during processing.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
650-0010-PX01 | EVOLUTE® EXPRESS SORBENT SELECTION 10 mg Fixed Well Plate | 1 | 314 USD | Add to quote/cart |
650-0030-PX01 | EVOLUTE® EXPRESS SORBENT SELECTION 30 mg Fixed Well Plate | 1 | 321 USD | Add to quote/cart |
602-0010-PX01 | EVOLUTE® EXPRESS WCX 10 mg Fixed Well Plate | 1 | 314 USD | Add to quote/cart |
602-0001-AXG | EVOLUTE® EXPRESS WCX 10 mg/1 mL (Tabless) | 100 | 246 USD | Add to quote/cart |
612-0010-BXG | EVOLUTE® EXPRESS WCX 100 mg/3 mL (Tabless) | 50 | 263 USD | Add to quote/cart |
612-0015-CXG | EVOLUTE® EXPRESS WCX 150 mg/6 mL (Tabless) | 30 | 207 USD | Add to quote/cart |
602-0030-PX01 | EVOLUTE® EXPRESS WCX 30 mg Fixed Well Plate | 1 | 321 USD | Add to quote/cart |
602-0003-AXG | EVOLUTE® EXPRESS WCX 30 mg/1 mL (Tabless) | 100 | 282 USD | Add to quote/cart |
612-0050-CXG | EVOLUTE® EXPRESS WCX 500 mg/6 mL (Tabless) | 30 | 317 USD | Add to quote/cart |
602-0060-PX01 | EVOLUTE® EXPRESS WCX 60 mg Fixed Well Plate | 1 | 324 USD | Add to quote/cart |
612-0006-BX | EVOLUTE® EXPRESS WCX 60 mg/3 mL | 50 | 182 USD | Add to quote/cart |
612-0006-BXG | EVOLUTE® EXPRESS WCX 60 mg/3 mL (Tabless) | 50 | 182 USD | Add to quote/cart |
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs over 500 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Copyright © 2023 Biotage